Multiple gastrointestinal stromal tumors: analysis of clinicopathologic characteristics and prognosis of 20 patients

References

• Corless CL, Barnett CM, Heinrich MC. Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer. 2011;11(12):865–878. doi:10.1038/nrc314322089421
   PubMed Web of Science ®Google Scholar
• Søreide K, Sandvik OM, Søreide JA, et al. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39–46. doi:10.1016/j.canep.2015.10.03126618334
   PubMed Web of Science ®Google Scholar
• Kim KH, Nelson SD, Kim DH, et al. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases. Anticancer Res. 2012;32(3):923–937.22399613
   PubMed Web of Science ®Google Scholar
• Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299(5607):708–710. doi:10.1126/science.107966612522257
   PubMed Web of Science ®Google Scholar
• Neuhann TM, Mansmann V, Merkelbach-Bruse S, et al. A novel germline KIT mutation (p.L576P) in a family presenting with juvenile onset of multiple gastrointestinal stromal tumors, skin hyperpigmentations, and esophageal stenosis. Am J Surg Pathol. 2013;37(6):898–905. doi:10.1097/PAS.0b013e31827bc07123598963
   PubMed Web of Science ®Google Scholar
• Agaimy A, Vassos N, Croner RS. Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen’s disease): clinicopathological spectrum with pathogenetic considerations. Int J Clin Exp Pathol. 2012;5(9):852–862.23119102
   PubMed Web of Science ®Google Scholar
• Carney JA. Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin Proc. 1999;74(6):543–552. doi:10.4065/74.6.54310377927
   PubMed Web of Science ®Google Scholar
• Kang DY, Park CK, Choi JS, et al. Multiple gastrointestinal stromal tumors: clinicopathologic and genetic analysis of 12 patients. Am J Surg Pathol. 2007;31(2):224–232. doi:10.1097/01.pas.0000213318.66800.9417255767
   PubMed Web of Science ®Google Scholar
• Haller F, Schulten HJ, Armbrust T, et al. Multicentric sporadic gastrointestinal stromal tumors (GISTs) of the stomach with distinct clonal origin: differential diagnosis to familial and syndromal GIST variants and peritoneal metastasis. Am J Surg Pathol. 2007;31(6):933–937. doi:10.1097/01.pas.0000213440.78407.2717527083
   PubMed Web of Science ®Google Scholar
• Gasparotto D, Rossi S, Bearzi I, et al. Multiple primary sporadic gastrointestinal stromal tumors in the adult: an underestimated entity. Clin Cancer Res. 2008;14(18):5714–5721. doi:10.1158/1078-0432.CCR-08-0622
   Web of Science ®Google Scholar
• Agaimy A, Märkl B, Arnholdt H, et al. Multiple sporadic gastrointestinal stromal tumours arising at different gastrointestinal sites: pattern of involvement of the muscularis propria as a clue to independent primary GISTs. Virchows Arch. 2009;455(2):101–108. doi:10.1007/s00428-009-0803-119572146
   PubMed Web of Science ®Google Scholar
• Agaimy A, Dirnhofer S, Wünsch PH, et al. Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect. Am J Surg Pathol. 2008;32(10):1553–1559. doi:10.1097/PAS.0b013e31817587ea18724245
   PubMed Web of Science ®Google Scholar
• Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008;39(10):1411–1419. doi:10.1016/j.humpath.2008.06.02518774375
   PubMed Web of Science ®Google Scholar
• Chen LL, Trent JC, Wu EF, et al. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res. 2004;64(17):5913–5919. doi:10.1158/0008-5472.CAN-04-008515342366
   PubMed Web of Science ®Google Scholar
• Matyakhina L, Bei TA, McWhinney SR, et al. Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. J Clin Endocrinol Metab. 2007;92(8):2938–2943. doi:10.1210/jc.2007-079717535989
   PubMed Web of Science ®Google Scholar
• Carney JA, Stratakis CA, Young WF. Adrenal cortical adenoma: the fourth component of the Carney triad and an association with subclinical Cushing syndrome. Am J Surg Pathol. 2013;37(8):1140–1149. doi:10.1097/PAS.0b013e318285f6a223681078
   PubMed Web of Science ®Google Scholar
• Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet. 2013;382(9896):973–983. doi:10.1016/S0140-6736(13)60106-323623056
   PubMed Web of Science ®Google Scholar
• Chen CF, Chuang CH, Liu MK, et al. Clinical, radiologic and pathologic characteristics of the carney triad: a case report and literature review. Kaohsiung J Med Sci. 2010;26(8):428–434. doi:10.1016/S1607-551X(10)70069-320705254
   PubMed Web of Science ®Google Scholar
• Kawanowa K, Sakuma Y, Sakurai S, et al. High incidence of microscopic gastrointestinal stromal tumors in the stomach. Hum Pathol. 2006;37(12):1527–1535. doi:10.1016/j.humpath.2006.07.00216996566
   PubMed Web of Science ®Google Scholar
• Joensuu H, Eriksson M, Sundby Hall K, et al. One vs. three years of adjuvant imatinib for operable gastrointestinal stromal tumor. JAMA. 2014;307(12):1265–1272. doi:10.1001/jama.2012.347
   Web of Science ®Google Scholar
• Debiec-Rychter M, Sciot R, Le Cesne A, et al. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer. 2006;42(8):1093–1103. doi:10.1016/j.ejca.2006.01.03016624552
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Tobo T, Nakamori M, et al. Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q. J Cancer Res Clin Oncol. 2009;135(6):791–798. doi:10.1007/s00432-008-0514-z19020900
   PubMed Web of Science ®Google Scholar
• Haller F, Moskalev EA, Faucz FR, et al. Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad. Endocr Relat Cancer. 2014;21(4):567–577. doi:10.1530/ERC-14-025424859990
   PubMed Web of Science ®Google Scholar
• Joensuu H, Vehtari A, Riihimäki J, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012;13(3):265–274. doi:10.1016/S1470-2045(12)70140-722153892
   PubMed Web of Science ®Google Scholar
• Salvi PF, Lorenzon L, Caterino S, et al. Gastrointestinal stromal tumors associated with neurofibromatosis 1: a single centre experience and systematic review of the literature including 252 cases. Int J Surg Oncol. 2013;2013:398570.24386562
   PubMedGoogle Scholar